Skip to content
HowShorted

Nuvation Bio Inc. short interest in 2025

In 2025, Nuvation Bio Inc.'s disclosed short interest ran from 6.55% of shares outstanding on 15 Jan 2025 to 12.18% on 31 Dec 2025, a change of +5.63 percentage points. The year's high was 23.14% on 15 Oct 2025 and its low 6.55% on 15 Jan 2025, averaging 14.62% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.25 days on 31 Jul 2025. Full history: Nuvation Bio Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Nuvation Bio Inc. in 2025

2025 in figures

Start of year
6.55% (15 Jan 2025)
End of year
12.18% (31 Dec 2025)
Change
+5.63 pp
High
23.14% (15 Oct 2025)
Low
6.55% (15 Jan 2025)
Average
14.62%
Highest days to cover
16.25 (31 Jul 2025)
SEC filings marked
8

Every report in 2025

Nuvation Bio Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20256.55%6.56
31 Jan 20257.49%10.01
14 Feb 20257.78%15.14
28 Feb 20257.33%14.58
14 Mar 20258.44%6.8810-K filed, results (8-K)
31 Mar 20259.54%14.50
15 Apr 20259.15%8.13
30 Apr 20259.73%11.84
15 May 202511.12%11.2310-Q filed, results (8-K)
30 May 202512.44%8.51
13 Jun 202516.48%6.40
30 Jun 202519.32%7.11
15 Jul 202520.95%11.78
31 Jul 202520.40%16.25
15 Aug 202520.18%14.2510-Q filed, results (8-K)
29 Aug 202519.91%15.24
15 Sep 202519.87%7.62
30 Sep 202521.03%10.37
15 Oct 202523.14%12.11
31 Oct 202519.74%6.83
14 Nov 202519.35%8.0710-Q filed, results (8-K)
28 Nov 202515.34%3.63
15 Dec 202513.41%7.31
31 Dec 202512.18%7.46

See also: Nuvation Bio Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.